Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 182,700 | 93,600 | 85,100 | 104,600 | 15,400 |
| Receivables | 1,130,100 | 1,115,600 | 787,800 | 973,400 | 845,100 |
| Inventories | 1,937,800 | 1,663,100 | 915,700 | 956,200 | 835,800 |
| Other current assets | 679,500 | 320,400 | 853,300 | 247,400 | 206,800 |
| TOTAL | $3,930,100 | $3,192,700 | $2,641,900 | $2,281,600 | $1,903,100 |
| Non-Current Assets | |||||
| PPE Net | 1,708,200 | 1,679,600 | 1,219,500 | 1,358,900 | 1,189,600 |
| Investments And Advances | 179,900 | 1,243,400 | 137,800 | 74,900 | 76,000 |
| Intangibles | 8,038,700 | 6,880,500 | 3,237,200 | 3,328,600 | 2,332,700 |
| Other Non-Current Assets | 811,400 | 205,300 | 647,200 | 400,900 | 320,800 |
| TOTAL | $10,738,200 | $10,008,800 | $5,241,700 | $5,163,300 | $3,919,100 |
| Total Assets | $14,668,300 | $13,201,500 | $7,883,600 | $7,444,900 | $5,822,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,700 | 296,900 | 400 | 200,500 | 132,900 |
| Accounts payable and accrued liabilities | 469,300 | 688,400 | 271,200 | 316,400 | 268,200 |
| Accrued Expenses | 908,900 | 995,500 | 588,900 | 718,900 | 606,500 |
| Other current liabilities | N/A | N/A | 7,200 | 24,700 | 29,100 |
| TOTAL | $2,515,400 | $2,817,900 | $2,036,000 | $2,133,500 | $1,514,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,034,900 | 4,889,900 | 1,239,500 | 1,242,600 | 841,700 |
| Other Non-Current Liabilities | 1,239,600 | 851,700 | 885,600 | 843,300 | 881,300 |
| TOTAL | $7,424,900 | $6,738,000 | $2,716,900 | $2,591,900 | $1,994,300 |
| Total Liabilities | $9,940,300 | $9,555,900 | $4,752,900 | $4,725,400 | $3,509,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 152,459 | 146,345 | 144,886 | 146,280 | 146,618 |
| Common Shares | 734,000 | 717,400 | 717,400 | 717,400 | 717,400 |
| Retained earnings | 6,496,300 | 5,890,200 | 5,447,200 | 4,925,800 | 4,529,900 |
| Other shareholders' equity | 44,000 | -15,800 | 13,300 | -82,400 | -170,100 |
| TOTAL | $4,728,000 | $3,645,600 | $3,130,700 | $2,719,500 | $2,313,200 |
| Total Liabilities And Equity | $14,668,300 | $13,201,500 | $7,883,600 | $7,444,900 | $5,822,200 |